Liver Fibroses
33
5
7
16
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.1%
2 terminated out of 33 trials
88.9%
+2.4% vs benchmark
3%
1 trials in Phase 3/4
19%
3 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (33)
EUS Elastography for Predicting Cirrhotic-related Complications
Integrated Diagnostics for Early Diagnosis of Liver Disease
Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults
Incidence of HANA Conditions in HIV-infected Individuals
A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)
Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
Zinc Sulphate in Treatment Fibrosis in HBV Patient Receiving Antiviral Therapy
Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients
Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference
The Use of Novel Diagnostic Tools to Increase Detection of Early Fibrosis in Cystic Fibrosis Related Liver Disease to Improve Clinical Management
Liver, Pancreas and Thyroid Function in Burn Patients
The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF
Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.
Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment
The EUS ShearWave Elastography Liver Fibrosis Study
Competitive Accuracy of Radiological Imaging Compared to Liver Biopsy in Patients With Liver Fibrosis
A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH
Liquid Biopsy for NASH and Liver Fibrosis
Evaluation of the Effect of IHHT on Vascular Stiffness and Elasticity of the Liver Tissue in Patients With MS.
SWE Liver Stiffness as a Predictor of Progression of Chronic Liver Diseases